Medication safety in the context of family caregiving is a multifaceted issue that intersects with cognitive decline, polypharmacy, socio-economic factors, and caregiver burden. Older adults often juggle multiple chronic conditions, necessitating complex pharmacological regimens that increase the risk of adverse drug events. This study’s methodology emphasized in-situ assessment, recognizing that hospital or clinical data alone fail to capture the intricacies of medication management as it unfolds within the realities of a patient’s home and daily routines.

The research team’s approach involved direct, face-to-face interviews with both caregivers and older adults. These dialogues provided qualitative data illuminating the caregivers’ knowledge, attitudes, and perceived challenges regarding medication administration. Importantly, the interactions revealed a recurring theme: despite caregivers’ best intentions, there was often a lack of comprehensive understanding about medication purposes, dosing schedules, and potential side effects. This knowledge gap can lead to inadvertent medication errors or non-adherence, amplifying health risks over time.

Observational insights collected during home visits were equally revealing. Researchers documented non-standardized medication storage practices, such as pills kept in non-original containers or alongside unrelated items, increasing the potential for dosing mistakes. Physical environments varied widely, with some homes lacking adequate lighting or organizational tools to facilitate safe medication handling, underscoring environmental risk factors that conventional healthcare settings rarely address.

The cornerstone of the study was the detailed medication review performed by clinical pharmacists. This comparative analysis between prescribed regimens and actual medication usage unveiled discrepancies often rooted in communication lapses between healthcare providers, patients, and caregivers. Polypharmacy — the concurrent use of multiple medications — emerged as a critical factor intricately linked with these discrepancies, highlighting the necessity for regular medication reconciliation at the household level, not just in clinical consultations.

Significantly, the research highlighted that medication safety is not merely a clinical issue but a socio-technical challenge involving the interaction of human behavior, caregiver education, healthcare communication, and the physical environment. Caregivers frequently operated under stress and time constraints which compounded the risk of medication mishandling. The study advocates for systemic support measures that transcend standard medical advice, proposing enhanced caregiver training programs designed around real-world home dynamics.

This investigation also addressed the technological dimension of home medication management. While digital tools and reminders hold promise for improving adherence, their adoption by older adults and caregivers remains inconsistent. Factors such as technological literacy, accessibility, and user-friendliness must be carefully considered when integrating such innovations. Tailoring technology to individual household needs is essential to ensure practical utility without adding complexity to already strained caregiving routines.

From a clinical perspective, the study reinforces the necessity for healthcare providers to engage proactively with family caregivers. Structured communication pathways and regular check-ins could bridge knowledge gaps and empower caregivers with the information and resources needed to manage polypharmacy effectively. Moreover, personalized care plans that involve caregivers as integral partners may reduce preventable medication errors and enhance overall treatment outcomes.

The implications of this study extend beyond individual households to inform health policy and healthcare system design. As the reliance on family caregiving intensifies globally, frameworks must evolve to embed medication safety within community-based care strategies. This entails not only education and monitoring but also expanding access to interdisciplinary support, including pharmacists, nurses, and social workers who can conduct home visits and intervene promptly when risks are detected.

In assessing the broader ramifications, the study highlights the silent epidemic of medication-related harm that often goes unreported or unnoticed in older adult populations residing outside institutional care. Despite the availability of potent therapeutic agents, the absence of robust safety nets in home environments can negate clinical benefits, leading to hospitalizations, deterioration of health status, and diminished quality of life. Recognizing family caregivers as pivotal allies in safeguarding medication safety alters the paradigm towards more inclusive, patient-centered care models.

Furthermore, the research underscores ethical considerations surrounding caregiver capacity and well-being. Overburdened caregivers without adequate support may inadvertently compromise medication safety. Therefore, interventions must also address caregiver mental health and resilience, promoting sustainable caregiving that benefits both older adults and their families. Future research could explore tailored psychosocial support integrated with medication management education to optimize outcomes holistically.

The study’s rigorous qualitative design and comprehensive data collection methods set a benchmark for future investigations in geriatric pharmacotherapy. By integrating interviews, observations, and medication reviews within real-life settings, the researchers offer a multidimensional understanding rarely achieved through conventional clinical trials or retrospective analyses. This holistic perspective paves the way for more effective interventions targeting the root causes of medication safety challenges in family caregiving.

In summary, the 2026 study published in BMC Geriatrics elucidates critical vulnerabilities in medication management for older adults under family care. Home visits that combine conversational inquiry, environmental appraisal, and expert medication assessment provide a powerful lens to address this pressing issue. The findings advocate for systemic reforms emphasizing caregiver education, interdisciplinary collaboration, technological adaptation, and socio-environmental considerations to enhance the safety and efficacy of medication use among aging populations globally.

These insights arrive at a pivotal moment in healthcare evolution, as demographic shifts demand innovative solutions to ensure older adults receive safe, effective pharmacological treatments outside clinical walls. Embracing family caregivers as integral partners and equipping them with necessary tools and knowledge represents a paradigm shift poised to reduce preventable adverse medication events. As this study powerfully demonstrates, safeguarding medication safety at home is a complex but achievable goal with far-reaching implications for public health and elder care.

Subject of Research: Medication safety in family caregiving of older adults through home visits involving interviews, observations, and medication reviews.

Article Title: Medication safety in family caregiving of older adults: home visits including interviews, observations, and medication reviews.

Article References:
Kiiski, A., Airaksinen, M., Karasti, E. et al. Medication safety in family caregiving of older adults: home visits including interviews, observations, and medication reviews. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07721-2

Image Credits: AI Generated

The multidisciplinary expert panel behind this update includes 19 nationally recognized professionals spanning 14 states, all of whom bring specialized expertise ranging from pharmacy practice to physical therapy and psychology. Among these contributors is Dr. Noll Campbell of the Regenstrief Institute and Purdue University College of Pharmacy—the sole expert representing Indiana—whose insights were instrumental in fortifying the clinical relevance and practical applicability of the recommendations. Their united effort underscores a paradigm shift from abstinence-focused directives to actionable alternatives that align with patient-centered goals and real-world clinical intricacies.

At the heart of the Beers Criteria lies the identification of medications whose side effect profiles—such as sedation, risk of falls, delirium, and detrimental drug-disease interactions—pose heightened dangers to aging physiology. However, prior iterations often faced criticism for their limited guidance beyond indicating what drugs to avoid. Addressing this gap, the AGS update introduces a sophisticated framework that empowers clinicians with clear, symptom-oriented tables of alternative therapies, inclusive of pharmacologic substitutes and non-drug interventions grounded in robust clinical evidence.

A transformative feature of this initiative is its patient and caregiver-centric approach. Recognizing that medication safety extends beyond prescriber decisions, the AGS has developed a suite of educational materials designed to facilitate informed dialogue, support deprescribing processes, and foster sustainable lifestyle adjustments. This aligns with contemporary emphasis on shared decision-making and highlights the necessity of equipping users at all levels with accessible, trustworthy resources to navigate complex treatment landscapes.

Categorically, the expert panel divided their work into eight focused domains: insomnia and anxiety; allergy and pruritus; cardiovascular and anticoagulation therapies; pain management; delirium and dementia; diabetes control; gastrointestinal syndromes; and genitourinary disorders. Each subgroup conducted meticulous reviews of contemporary, high-quality guidelines and systematic reviews tailored to geriatric populations, prioritizing U.S.-based standards while incorporating international data where methodological rigor and recency justified inclusion. This exhaustive process distilled alternatives pertinent to 21 frequently encountered conditions, underscoring the importance of treating underlying etiologies rather than symptoms alone.

For instance, cognitive behavioral therapy emerges as a front-line non-pharmacologic treatment for insomnia, addressing the disorder’s neurobehavioral roots without introducing sedative risks. Similarly, therapeutic exercise and physical therapy feature prominently for Parkinson’s disease management, mitigating motor symptoms and potentially slowing functional decline through neuroplasticity-enhancing mechanisms. Lifestyle interventions for constipation and dietary modifications for heartburn exemplify tailored approaches that favor physiological normalization over symptomatic suppression. Behavioral and dietary strategies also serve as pivotal alternatives to medication for urinary symptoms, reflecting an adaptive, minimally invasive paradigm focused on quality of life.

Central to the AGS recommendations are five guiding principles designed to recalibrate clinician perspectives: prioritizing patient well-being over mere drug discontinuation; advocating non-pharmacologic methods as initial interventions; rigorously investigating symptom origins prior to prescribing; maintaining nuanced clinical judgment that balances risks and benefits; and leveraging comprehensive resources for both deprescribing and patient empowerment. This framework acknowledges the clinical complexity and heterogeneity inherent in geriatric care, advocating for flexible, individualized treatment plans informed by functional goals and patient preferences.

The panel openly acknowledges the challenges posed by existing literature, which often falls short in addressing the nuances of the oldest and most medically complex patients. The presentation of flexible recommendations encourages clinicians to adapt interventions as patients’ conditions evolve. Such responsiveness is particularly critical given that abrupt medication cessation may precipitate symptom recurrence or exacerbation, potentially undermining therapeutic gains. This reality underscores the necessity for readily implementable alternative treatments that preserve symptom control while minimizing harm.

Dr. Campbell emphasizes that this update aims not merely to issue cautionary advisories but to equip clinicians with tangible tools and actionable pathways toward safer, more effective care. The transition from warnings to solutions epitomizes a modern approach to medication safety, wherein actionable alternatives foster empowerment rather than reluctance. This approach harmonizes with the broader movement within geriatric medicine towards comprehensive, team-based, and patient-centered care models.

Beyond the clinical sphere, the inclusion of patient- and caregiver-facing decision aids reflects a commitment to democratizing healthcare knowledge and fostering autonomy. These materials simplify complex medical information, enabling users to engage meaningfully in care decisions and enhancing adherence to deprescribing and lifestyle interventions. This innovation recognizes the critical role of caregivers and patients as active participants in managing geriatric conditions, particularly in settings such as homes and nursing facilities where medication-related harms often manifest.

The publication of this work in the peer-reviewed Journal of the American Geriatrics Society solidifies its scholarly and clinical credibility. By disseminating these evidence-based alternatives through a respected platform, the AGS aims to accelerate their adoption and influence clinical practices nationwide. The broad geographic representation of the panel—from states including California, Texas, New York, and others—further ensures that perspectives reflect a diverse array of healthcare environments and patient demographics.

Ultimately, the 2023 update to the AGS Beers Criteria alternatives list represents a paradigm shift in geriatric medication safety—from a focus on exclusion to an emphasis on inclusion of safer, evidence-based options. Integrating pharmacologic and non-pharmacologic strategies with patient education and interdisciplinary collaboration, the initiative embodies a forward-looking vision to enhance health outcomes for older adults. This comprehensive approach not only mitigates medication-related risks but also fosters functional independence, symptom relief, and improved quality of life—pillars essential to the future of aging care.

Subject of Research: Alternatives to potentially inappropriate medications for older adults as outlined in the 2023 American Geriatrics Society Beers Criteria®

Article Title: Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria®

News Publication Date: 23-Jul-2025

Web References: http://dx.doi.org/10.1111/jgs.19500

References: Published in the Journal of the American Geriatrics Society

Keywords: Health and medicine